568 related articles for article (PubMed ID: 26004524)
1. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
Zhang L; Tu Y; He W; Peng Y; Qiu Z
Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
3. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.
Li Z; Tan F; Thiele CJ
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3113-21. PubMed ID: 18089706
[TBL] [Abstract][Full Text] [Related]
5. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
6. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
7. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Park N; Baek HS; Chun YJ
PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
[TBL] [Abstract][Full Text] [Related]
8. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
[TBL] [Abstract][Full Text] [Related]
9. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
[TBL] [Abstract][Full Text] [Related]
10. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
[TBL] [Abstract][Full Text] [Related]
11. GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.
Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Cadoret A; Capeau J; Desbois-Mouthon C
Int J Oncol; 2005 Jul; 27(1):215-22. PubMed ID: 15942663
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
13. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways.
Xia Y; Wang CZ; Liu J; Anastasio NC; Johnson KM
Neuropharmacology; 2010 Feb; 58(2):330-6. PubMed ID: 19887077
[TBL] [Abstract][Full Text] [Related]
15. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
16. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
17. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
[TBL] [Abstract][Full Text] [Related]
18. LPLI inhibits apoptosis upstream of Bax translocation via a GSK-3beta-inactivation mechanism.
Zhang L; Zhang Y; Xing D
J Cell Physiol; 2010 Jul; 224(1):218-28. PubMed ID: 20333643
[TBL] [Abstract][Full Text] [Related]
19. Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis.
Sophia J; Kiran Kishore T K; Kowshik J; Mishra R; Nagini S
Sci Rep; 2016 Feb; 6():22192. PubMed ID: 26902162
[TBL] [Abstract][Full Text] [Related]
20. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST
Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
